VICTORY CAPITAL MANAGEMENT INC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$19,000
-44.1%
16,075
-15.4%
0.00%
Q2 2022$34,000
-10.5%
19,000
+0.5%
0.00%
Q1 2022$38,000
-20.8%
18,912
+6.4%
0.00%
Q4 2021$48,000
-35.1%
17,774
+6.5%
0.00%
Q3 2021$74,000
-16.9%
16,696
+9.0%
0.00%
Q2 2021$89,000
-20.5%
15,324
-4.0%
0.00%
Q1 2021$112,000
+67.2%
15,964
+14.8%
0.00%
Q4 2020$67,000
-13.0%
13,908
+5.5%
0.00%
Q3 2020$77,000
-12.5%
13,180
+1.2%
0.00%
Q2 2020$88,000
-37.1%
13,019
-40.5%
0.00%
Q1 2020$140,000
+300.0%
21,884
+146.6%
0.00%
Q3 2019$35,000
+288.9%
8,876
+4596.3%
0.00%
Q2 2018$9,000
-98.8%
189
-98.7%
0.00%
-100.0%
Q1 2018$772,000
+5838.5%
14,629
+7640.2%
0.00%
Q4 2017$13,000
-18.8%
1890.0%0.00%
Q3 2017$16,000
-11.1%
1890.0%0.00%
Q2 2017$18,000
-98.7%
189
-99.1%
0.00%
-100.0%
Q1 2017$1,362,000
+16925.0%
21,393
+11463.8%
0.00%
Q4 2016$8,000
+33.3%
185
+6.3%
0.00%
Q3 2016$6,000
+200.0%
174
+8.1%
0.00%
Q2 2016$2,000
-33.3%
161
+2.5%
0.00%
Q1 2016$3,000
-40.0%
157
+9.0%
0.00%
Q4 2015$5,000
-58.3%
144
+7.5%
0.00%
Q3 2015$12,000
+9.1%
134
+10.7%
0.00%
Q2 2015$11,0001210.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders